HFE gene mutations in Polish patients with disturbances of iron metabolism: An initial assessment

International Journal of Molecular Medicine

Volumn 16, Issue 6, 2005, Pages 1151-1156

  Sikorska, Katarzyna ^a   Bielawski, Krzysztof Piotr ^b   Stalke, Piotr ^a   Lakomy, Elzbieta Anna ^a   Michalska, Zofia ^a   Witczak Malinowska, Krystyna ^a   Romanowski, Tomasz ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Hemochromatosis; Hepatitis C virus; Molecular diagnostic techniques; PCR RFLP

Indexed keywords

HEMOCHROMATOSIS PROTEIN; INTERFERON; RIBAVIRIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS C; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; HETEROZYGOTE; HFE GENE; HOMOZYGOTE; HUMAN; IRON METABOLISM DISORDER; IRON OVERLOAD; MALE; MIDDLE AGED; POLAND; POLISH CITIZEN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BLOOD ANALYSIS; ETHNOLOGY; GENETICS; HEPATITIS C VIRUS; METABOLISM; MUTATION; PATHOGENICITY;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; FEMALE; HEPACIVIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON METABOLISM DISORDERS; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; POLAND; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33644876821     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.16.6.1151     Document Type: Article

References (40)

1. Bacon BR: Hemochromatosis: diagnosis and management. Gastroenterology 120: 718-725, 2001.
2. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA and Kirsch RE: Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 25: 633-638,1996.
3. Bonkovsky HL, Lambrecht RW and Shan Y: Iron as a comorbid factor in nonhemochromatotic liver disease. Alcohol 30: 137-144, 2003.
4. Farinati F, Cardin R, De Maria N, et at. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive patients. J Hepatol 22: 449-456, 1995.
5. Pagano G, Pacini G and Musso G: Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372, 2002.
6. Pietrangelo A: Iron oxidative stress and liver fibrogenesis. J Hepatol 28 (suppl. 1): 8-13,1998.
7. Bonkovsky HL and Lambrecht RW: Iron-induced liver injury. Clin Liver Dis 4: 409-429, 2000.
8. Videla LA, Fernandez V, Tapia G and Varela P: Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupfer cells. Biometals 16: 103-111,2003.
9. Deugnier Y, Turlin B and Loreal O: Iron and neoplasia. J Hepatol 28: 21-25,1998.
10. Feder IN, Gnirke A, Thomas W, et at. A novel MHC class Hike gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13: 399-409,1996.
11. Brissot P, Moirand R, Jouanolle AM, et at A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 30: 588-593, 1999.
12. Mura C, Nousbaum JB, Verger P, et at. Phenotype-genotype correlation in haemochromatosis subjects. Hum Genet 101: 271-276,1997.
13. Fodinger M and Sunder-Plassmann G: Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing? Eur J Clin Invest 33: 737-739, 2003.
14. Philpott CC: Molecular aspects of iron absorption: insights into the role of HFE in hemochromatosis. Hepatology 35: 993-1001, 2002.
15. Bonkovsky HL, Banner BF and Rothman AL: Iron and chronic viral hepatitis. Hepatology 25: 759-768,1997.
16. George DK, Goldwurm S, MacDonald GA, et at. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311-318,1998.
17. Martinelli AL, Franco RF, Villanova MG, et at. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection. Acta Haematol 102: 152-156,2000.
18. Smith BC, Gorve J, Guzail MA, Day CP, Daly AK and Burt AD: Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27: 1695-1699,1998.
19. Bonkovsky HL, Jawaid Q, Tortorelli K, et at. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31: 421-429,1999.
20. Åsberg A, Hveem K, Thorstensen K, et at. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65238 persons. Scand J Gastroenterol 36:1108-1115,2001.
21. Beutler E, Felitti VJ, Koziol JA, Ho NJ and Gelbart T: Penetrance of 845G->A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359: 211-218, 2002.
22. Jackson HA, Carter K, Darke C, et at. HFE mutations, iron deficiency and overload in 10500 blood donors. Br J Haematol 114:474-484,2001.
23. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L and Powell LW: A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341: 718-724, 1999.
24. Fargion S, Fracanzani AL, Sampietro M, et at. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 9: 497-503,1997.
25. Sikorska K, Stalke P, Lakomy EA, Michalska Z, Witczak-Malinowska K and Stolarczyk J: Disturbances of iron metabolism in chronic liver diseases. Med Sci Monit 9 (suppl. 3): 64-67, 2003.
26. Menghini G: The needle biopsy of the liver, an effective technical progress. Sci Med Ital 6: 212-229,1957.
27. Harrison SA and Bacon BR: Hereditary hemochromatosis: update for 2003. J Hepatol 38: S14-S23,2003.
28. Metwally MA, Zein CO and Zein NN: Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 99: 286-291, 2004.
29. Thorburn D, Curry G, Spooner R, et at. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50: 248-252, 2002.
30. Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q and Hsieh CC: Iron and HFE or TfRl mutation as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 36: 848-854, 2002.
31. Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C and Haussinger D: HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. Hepatology 38: 335-342, 2003.
32. Gehrke SG, Stremmel W, Mathes I, Riedel HD, Bents K and Kallinowski B: Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. J Mol Med 81: 747-749,2003.
33. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ and Kovdley KV: Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 124: 318-326, 2003.
34. Fong TL, Han SH, Tsai NCS, et al: A pilot randomized, controlled trial of the effect of iron depletion on long term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol 28: 369-374,1998.
35. Fontana RJ, Israel J, LeClear P, et al: Iron reduction before and during interferon therapy of chronic hepatitis C. Results of a multicenter, randomized, controlled trial. Hepatology 31: 730-736, 2000.
36. Kato J, Kobune M, Nakamura T, et al: Normalisation of elevated hepatic 8-hydroxy-2'deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 61: 8697-8702, 2001.
37. Fargion S, Fracanzani AL, Rossini A, et al: Iron reduction and sustained response to interferon-alfa therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Am J Gastroenterol 97: 1204-1210,2002.
38. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E and Olynyk JK: A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gatroenterology 122: 646-651,2002.
39. Lebray P, Zylberberg H, Hue S, et al: Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C. J Viral Hepat 11: 175-182, 2004.
40. Zych WS, Habior A, Rawa T, Butruk E and Ostrowski J: Hemochromatoza wrodzona - pilotowe badanie oceny czestosci wystepowania w wyselekcjonowanej populacji. Proc and abs book of the XI Congress of Polish Gastroenterologists: pp72-73, 2004.